{"organizations": [], "uuid": "fe3502627ebf53aa11642402094ffdb95f342b4c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://yospace-cds1.reuters.com/u/resize~ad1~1200ce65e85c3f3?width=640&location=LANDSCAPE&videoId=OV7WF4DJF", "site_section": "http://feeds.reuters.com/reuters/INVideoWorldNews\r", "section_title": "Reuters Video: World News", "url": "https://in.reuters.com/video/2018/01/03/new-drug-approvals-hit-21-year-high?videoId=377794973", "country": "US", "domain_rank": 408, "title": "New drug approvals hit 21 year high", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T06:33:00.000+02:00", "replies_count": 0, "uuid": "fe3502627ebf53aa11642402094ffdb95f342b4c"}, "author": "", "url": "https://in.reuters.com/video/2018/01/03/new-drug-approvals-hit-21-year-high?videoId=377794973", "ord_in_thread": 0, "title": "New drug approvals hit 21 year high", "locations": [], "entities": {"persons": [{"name": "fred katayama", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "New drug approvals hit 21 year high 10:03am IST - 01:12 \nU.S. drug approvals more than doubled in 2017 over the previous year. Fred Katayama reports on what's behind the acceleration of approvals.   \nU.S. drug approvals more than doubled in 2017 over the previous year. Fred Katayama reports on what's behind the acceleration of approvals.  //reut.rs/2Ab48U2", "external_links": [], "published": "2018-01-03T06:33:00.000+02:00", "crawled": "2018-01-03T07:03:20.016+02:00", "highlightTitle": ""}